Extensively Drug-Resistant Tuberculosis
Showing 1 - 25 of >10,000
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid
Active, not recruiting
- Tuberculosis
- +4 more
- Bedaquiline Oral Tablet
- +7 more
-
Port Elizabeth, Eastern Cape, South Africa
- +1 more
Oct 20, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,
Active, not recruiting
- Tuberculosis, Pulmonary
- +5 more
- Pretomanid
- +3 more
-
Tbilisi, Georgia
- +10 more
Jan 26, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South
Active, not recruiting
- Multi-drug Resistant Tuberculosis
- +2 more
- Bedaquiline
- +4 more
-
Minsk, Belarus
- +4 more
May 12, 2021
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South
Recruiting
- Multi-drug Resistant Tuberculosis
- +2 more
- Bedaquiline
- +5 more
-
Minsk, Belarus
- +6 more
May 12, 2021
Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +5 more
-
Minsk, Belarus
- +6 more
May 12, 2021
Pre-Extensively Drug-Resistant Pulmonary TB, Treatment Intolerant Multidrug-Resistant Pulmonary TB, Non-responsive
Recruiting
- Pre-Extensively Drug-Resistant Pulmonary TB
- +2 more
- Linezolid
- +2 more
-
Agra, Uttarpradesh, IndiaS N Medical College
Nov 8, 2021
Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)
Completed
- Pulmonary Tuberculosis
- Bedaquiline
- +2 more
-
Ysterplaat, Cape Town, South Africa
- +2 more
Nov 19, 2020
Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)
Not yet recruiting
- Drug-resistant Tuberculosis
- +2 more
- Targeted next-generation sequencing
-
Cape Town, South AfricaSouth African National Health Laboratory Service
Sep 23, 2022
Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)
Not yet recruiting
- Multi Drug Resistant Tuberculosis
- HIV Infections
- Adherence support intevention
-
Durban, KwaZulu-Natal, South AfricaKing DinuZulu Hospital
Nov 21, 2022
Pharmacometrics to Advance Novel Regimens for Drug-resistant
Recruiting
- Multi-drug Resistant Tuberculosis
-
Almaty, Kazakhstan
- +6 more
Nov 1, 2022
Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)
Completed
- Tuberculosis, MDR
- FS-1
- Placebo
-
Semey, East-Kazakhstan Region, Kazakhstan
- +5 more
May 17, 2022
Interferon Gamma Injections in Drug-resistant Pulmonary
Recruiting
- Pulmonary Tuberculosis
-
Moscow, Russian FederationFSBI "NMIC FPI" of the Ministry of Health of Russia
May 31, 2022
Clinical Evaluation of tNGS for Diagnosis of DR-TB
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- targeted Next Generation Sequencing (tNGS)
-
Tbilisi, Georgia
- +2 more
Jan 23, 2023
Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg
Recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Linezolid 600 mg
- +7 more
-
Gaborone, South-East District, Botswana
- +16 more
Dec 13, 2022
Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for
Not yet recruiting
- Tuberculosis
- Rifampicin Resistant Tuberculosis
- Pretomanid
- Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
-
Rio De Janeiro, Brazil
- +6 more
Oct 18, 2022
Multidrug-resistant Tuberculosis
Recruiting
- Multi-Drug Resistant Tuberculosis
-
Paris, FrancePitié Salpêtrière Hospital
Mar 28, 2022
Promoting Engagement in Drug Resistant TB/HIV Care Continuum in
Completed
- Patient Non-compliance
-
Durban, Kwa-Zulu Natal, South AfricaKing Dinuzulu Hospital
Jul 19, 2022
Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)
Recruiting
- Pulmonary Tuberculosis
- WX-081
- +3 more
-
Beijing, Beijing, ChinaBeijing Chest Hospital affiliated to Capital Medical University
Dec 14, 2021
Tuberculosis, HIV Trial in Lima, Cape Town (Bedaquiline, Delamanid, Dolutegravir)
Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)
Not yet recruiting
- Tuberculosis, Multidrug-Resistant
- Targeted sequencing using the GenoScreen Deeplex assay
-
Cape Town, Western Cape, South AfricaUniversity of Cape Town
Sep 28, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, Multidrug Resistant Tuberculosis Trial in Bloemfontein (WGS DST
Recruiting
- Rifampicin Resistant Tuberculosis
- +3 more
- WGS DST strategy
-
Bloemfontein, Free State, South AfricaFree State Department of Health Clinics
Oct 14, 2021
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Recruiting
- Drug Resistant Tuberculosis
- +3 more
- Xpert® MTB/XDR
-
Gulele, Addis Ababa, Ethiopia
- +3 more
Jun 13, 2022